Kinouchi A, Ishii H, Sakamoto K, Sakurai D. Successful desensitization after hypersensitivity reaction to cisplatin in a patient with nasopharyngeal carcinoma.
Clin Case Rep 2022;
10:e6444. [PMID:
36285037 PMCID:
PMC9587507 DOI:
10.1002/ccr3.6444]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2022] [Revised: 09/16/2022] [Accepted: 09/26/2022] [Indexed: 11/11/2022] Open
Abstract
Hypersensitivity reaction to cisplatin can result in discontinuation of chemoradiotherapy in patients with head and neck squamous cell carcinoma. We describe a patient with nasopharyngeal carcinoma who developed cisplatin hypersensitivity and was successfully treated with cisplatin desensitization. Furthermore, it had little impact on the therapeutic performance of cisplatin‐combined chemoradiotherapy.
Cisplatin hypersensitivity can result in the discontinuation of chemoradiotherapy in patients with head and neck squamous cell carcinoma. Desensitization protocol had little impact on the therapeutic performance of cisplatin‐combined chemoradiotherapy.
Collapse